About the conference
The two-day conference was entirely dedicated to bringing together the latest advances, challenges and opportunities for developing medicinal products and medicinal devices for paediatric use from EU and US perspective. Specifically aimed at providing exposure to emerging practical applications and illustrate specific remedies utilized by paediatric drug development teams to overcome hurdles faced in developing medicines for 0-17 years old.
An exciting programme was organised to focus on three themes:
- state of the art plenary presentations [such as update on EMA guidelines on Pharmaceutical Development of Medicines for Paediatric Use, achievements of the WHO ‘Make Medicines Child Size’ programme, PK & bridging studies in paediatric drug development, AAPS white paper and FDA views,
- thematic sessions covering the five work streams of EuPFI including the launch of STEP database, and
- case studies, emerging technologies & research through soap box sessions and posters.
This conference offered an excellent and time-effective way of gaining updates on key themes, as well as interacting with colleagues from across industrial, regulatory, academic and clinical professions.
We invite you to note the dates of 5th EuPFI conference in your diary and begin planning your participation, as well as your abstract submissions.
European Paediatric Formulation Initiative in partnership with International Association for Pharmaceutical Technology.
Congress Center: Institute of Molecular Genetics of the ASCR, v.v.i. (IMG), Vídeňská 1083, 142 20 Prague 4, Czech Republic
|July 15th, 2012||Second announcement|
|March 5th, 2012||On-line registration and abstract submission open|
|June 1st, 2012||Abstract submission deadline EXTENDED to 15th June 2012|
|July 1st, 2012||Notification about abstract acceptance (preliminary date)|
September 19st to 20th, 2012
Preliminary programe is available for download in PDF format below.4th EuPFI Conference - Preliminary Program
Call for Abstracts & Submission Guidelines
The abstract submission is closed. Thank you very much for your contribution
Instructions for Poster and Oral Presenters
Oral presentations (except plenary and keynote) have a 12 minutes slot – please prepare a PowerPoint presentation that lasts for up to 10 minutes MAXIMUM to allow 2 minutes for discussion after your talk. This equates to roughly 10 slides including your title and acknowledgement slides.
Please make sure you finish your talk with in 10 minutes - it is a good idea to rehearse it beforehand to check your timings- to allow plenty of time for discussion from the audience. We will give you a warning at 9 minutes so you have a minute to wrap up. We will be very strict about timing and will stop you when your 10 minutes is up even if you have not finished. If you need any further information please do not hesitate to get in touch.
Power Point presentation of all speakers must be delivered to the resigistration desk on the first day of the conference, alternatively you can send the presentation to firstname.lastname@example.org. Conference organisers will be available to help you download and run-through.
Final program with the time and date of presentations will be posted on the congress web site by September 10th.
All participants are kindly recommended to register via Online Registration Form on APV website. Please read the instructions on the APV website carefully.
To benefit from the reduced early registration fee, please process your registration before July 15th, 2012.
Upon submitting the Registration Form, You will receive a confirmation by e-mail of your registration with the invoice.
All participants are kindly requested to register in advance by completing and submitting the Registration Form with the appropriate fees.
Please note unpaid pre-registration will not be considered as a valid registration unless fully paid and confirmed. Pre-registration summary therefore cannot be taken as a valid registration confirmation. Please make sure to pay your registration fee within the time frame for early or regular registration.
|Early bird||Full Fee|
|by July 15th|
Non-Member (Non Academic, Non Governmental)
|1075 €||1175 €|
|Member of APV (Non Academic, Non Governmental)||945 €||1045 €|
|Non-Member (Academic, Governmental)||425 €||475 €|
|Member of APV (Academic, Governmental)||360 €||410 €|
|Students (please enclose evidence*)||195 €||225 €|
Registration fees are stated including 20% VAT.
* Students have to submit a copy of their student ID to the Conference email/contact address or fax number. Please note that if we do not receive this certification within 7 days after your data submission your registration will not be considered as valid.
Delegate registration fee includes
- Admission to scientific sessions, exhibition and poster area
- Conference materials
- Coffee breaks
- Conference Dinner & Social Programme
The registration fees do not include insurance of participants against accidents, sickness, cancellation, theft, property damage or loss. Participants are advised to take out adequate personal insurance.
Upon receipt of the correct registration fee (clear of bank charges), each participant will receive a confirmation of registration. Please bring this confirmation to the Registration desk at the conference venue as proof of your registration. Confirmation will be sent upon receipt of payment.
All fees for the Conference registration should be paid in EUR (€), free of all bank charges.
- credit card payment (Visa, Eurocard/Mastercard)
- by bank transfer
Cancellation / Refund Policy
We would like to point out that participation can be cancelled free of charge within two weeks of registration via the web.
Publication in the list of participants
In case you wish not to include your name and email address in the list of participants please send email to the Conference secretariat.
The participant acknowledges that he/she has no right to lodge damage claims against the organisers should the holding of the Conference be hindered or prevented by unexpected political or economic events or generally by force majeure, or should the non-appearance of speakers or other reasons necessitate programme changes. With registration, the participant accepts this proviso.
List of Hotels
Participants should make their own hotel reservation referring to the APV seminar. Please use the form available on following link below for hotel bookings http://www.czech-in.org/eupfi/accommodation.aspx
List of Hotels
Distance from the venue
18 mins by bus
10 mins walk
All rates are including 14%VAT, municipal taxes and breakfast.
ONLINE RESERVATION FORM Reservation conditions CONCERNING QUESTIONS, CHANGES OR CANCELLATIONS, PLEASE, CONTACT THE ACCOMMODATION AGENT: CZECH-IN s.r.o. Prague Congress Centre 5. kvetna 65 140 21 Prague 4 Czech Republic Tel: +420 261 174 304 Fax: +420 261 174 307 E-mail: email@example.com
K Zelené louce 2a 140 00 Prag 4 - Krč |Phone: +420 246 020-004 |Fax: +42 246 020-155|E-mail: firstname.lastname@example.org
The The Emmy Residence is a well-appointed four-star hotel located in a peaceful area of Prague 4 – Krč in the neighbourhood of Kunratice Forest and the Institute for Clinical and Experimental Medicine (IKEM). The hotel features cheap accommodation in Prague 4 with above-standard spacious rooms with free WiFi and free parking places right at the hotel.
Distance from the venue: 800m/10min, walking distance http://www.emmy.cz/en/
Panorama Hotel ****
Milevska 7, 14063 Prague,Czech Republic |Phone: +420 26116-1111 |Fax: +42 26116-4141 |E-mail: email@example.com
Newly Ideally situated in a peaceful area just outside the city centre, the Panorama Hotel Prague is the perfect base from which to explore the city. It offers all the comforts and services of an international first class hotel, while being excellent value for money. With 450 king size double and twin rooms (mostly non-smoking), it is renowned for its deluxe American breakfast buffet, as well as the MEZZO restaurant, which offers mid-week business lunches and a-la-carte dinners. The casual Panorama Café is ideal for meeting friends or, for guests seeking some rest and relaxation, there is a wellness and fitness centre located on the top floor featuring a panoramic pool.
Distance from the venue: 7.5km/18mins – bus 193 to the Institute of Molecular Genetics of Academy of Sciences from station Sídliště Pankrác, located next to hotel http://www.panoramahotelprague.com/home?l=1Free transportation for conference participants who reserved the room through the Accommodation Agent is provided.
Plenary presentationsWelcome and Introduction Catherine Tuleu, PhD, Chair of EuPFI, UCL School of Pharmacy, London, United Kingdom
Prof. Jörg Breitkreutz, PhD, Heinrich-Heine-University Düsseldorf, Düsseldorf, GermanyComments on the EMA draft guideline: final steps towards a harmonized view between regulators and industry Diana van Riet-Nales, PharmD, Co-ordinator, Section Chemical Pharmaceutical Assessment (CFB),
Medicines Evaluation Board (MEB), Bilthoven, The NetherlandsAAPS paediatric task force and its White Paper Georgia Charkoftaki, PhD, University of Athens, School of Pharmacy, Laboratory of Biopharmaceutics
and Pharmacokinetics, Athens, GreeceReflection on the achievements of the ‘Make Medicines Child Size’ programme: what next?' Kris Weerasuriya, PhD, Medical Officer, Medicine Access and Rational Use (MAR), Essential Medicines and
Pharmaceutical Policies (EMP) World Health Organization (WHO), Geneva, SwitzerlandChallenges and opportunities for developing pediatric products: A FDA Perspective Mansoor A. Khan, R.Ph., PhD, Director of product quality research in the Center for Drug Evaluation
and Research at the US Food and Drug Administration, Silver Spring, United StatesPK & bridging studies in pediatric drug development
Benedicte Ricci, PhD, F. Hoffmann-La Roche, Basel, Switzerland
Focus Sessions Presentations
Focus Session: Extemporaneous preparations
Chair: Jeff Rothwell, Rosemount Pharmaceuticals Ltd, Leeds, United kingdom
Catrin Barker, Alder Hey Children's NHS Foundation Trust, Liverpool, and Cheshire Merseyside &
North Wales Medicines for Children Local Research Network, Liverpool, United Kingdom
Terry Ernest, PhD, GlaxoSmithKline, Harlow, United Kingdom
Caroline Le Barbier, PhD, EMA and FWG PDCO, London, United Kingdom
Focus Session: Excipients
Chair: Jörg Breitkreutz, PhD Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
Mark Turner BSc, PhD, MBChB, MRCP(UK), MRCPCH, DRCOG, Department of Women's and
Children's Health, Institute of Translational Medicine and School of Reproductive & Developmental
Medicine University of Liverpool, Liverpool, United Kingdom
Smita Salunke, EuPFI, London, United Kingdom
George P. Giacoia, MD, Eunice Kennedy Shriver NICHD, NIH, Bethesda, MD, United States
Focus Session: Administration Devices
Chair: Herbert Wachtel, PhD, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
Jenny Walsh, BPharm (Hons), PhD, MRPharmS Jenny Walsh Consulting Ltd, Nottingham, United
Needle free parenteral administration for children: current status and future trends, an
Anand Subramony, PhD, Principal fellow and Head, Novel Delivery Technology & Therapeutics, Novartis Institutes for Biomedical Research Inc., Cambridge, United States
Evidence Based Design Of Face Masks For Infants & Young Children
Israel Amirav, PhD, Pediatric Department, Sieff Hospital, Safed, Israel
Focus Session: Taste Masking and Taste Assessment
Chair: Catherine Tuleu, PhD, Chair of EuPFI, UCL School of Pharmacy, London, United Kingdom
Assoc. Prof. Mario G. Bianchetti, MD, Medical director at the integrated Department of Pediatrics,
Bellinzona-Mendrisio, and associate Professor at the University of Bern, Bellinzona, Switzerland
Prof. Wojciech Wroblewski, PhD, Warsaw University of Technology, Department of Microbioanalytics,
Focus Session: Age Appropriate Formulations
Chair: Sabine Desset-Brethes, PhD, Novartis Pharma, Basel, Switzerland
Fréderic Gerber, PhD, Glatt, Binzen, Germany
Robert Havenaar, PhD, TNO, Zeist, The Netherlands